These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 16127152
1. Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator. de Giorgio-Miller A, Bottoms S, Laurent G, Carmeliet P, Herrick S. Am J Pathol; 2005 Sep; 167(3):721-32. PubMed ID: 16127152 [Abstract] [Full Text] [Related]
2. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR, Silence J, Lemmens G, Frederix L, Collen D. Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [Abstract] [Full Text] [Related]
3. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. Wu JH, Diamond SL. J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094 [Abstract] [Full Text] [Related]
4. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. Pardes JB, Takagi H, Martin TA, Ochoa MS, Falanga V. J Cell Physiol; 1995 Jan; 162(1):9-14. PubMed ID: 7814454 [Abstract] [Full Text] [Related]
5. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Danø K, Rømer J. EMBO J; 2006 Jun 21; 25(12):2686-97. PubMed ID: 16763560 [Abstract] [Full Text] [Related]
7. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. Yasuoka H, Jukic DM, Zhou Z, Choi AM, Feghali-Bostwick CA. Arthritis Rheum; 2006 Sep 21; 54(9):3001-10. PubMed ID: 16947625 [Abstract] [Full Text] [Related]
8. Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice. Kurata K, Maruyama S, Kato S, Sato W, Yamamoto J, Ozaki T, Nitta A, Nabeshima T, Morita Y, Mizuno M, Ito Y, Yuzawa Y, Matsuo S. Am J Physiol Renal Physiol; 2009 Dec 21; 297(6):F1510-7. PubMed ID: 19934446 [Abstract] [Full Text] [Related]
9. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage. Knier B, Cordasic N, Klanke B, Heusinger-Ribeiro J, Daniel C, Veelken R, Hartner A, Hilgers KF. J Hypertens; 2011 Aug 21; 29(8):1602-12. PubMed ID: 21610512 [Abstract] [Full Text] [Related]
10. Plasminogen activation in healing human wounds. Schäfer BM, Maier K, Eickhoff U, Todd RF, Kramer MD. Am J Pathol; 1994 Jun 21; 144(6):1269-80. PubMed ID: 8203466 [Abstract] [Full Text] [Related]
11. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Lijnen HR, Wagner EF, Collen D. Thromb Haemost; 1997 Feb 21; 77(2):362-7. PubMed ID: 9157597 [Abstract] [Full Text] [Related]
12. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT, Sugiura Y, Laug WE, Sun B, Garcia A, DeClerck YA. J Cell Physiol; 1996 May 21; 167(2):333-40. PubMed ID: 8613475 [Abstract] [Full Text] [Related]
13. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice. Wang H, Zhang Y, Heuckeroth RO. Hepatology; 2007 Jun 21; 45(6):1527-37. PubMed ID: 17538930 [Abstract] [Full Text] [Related]
14. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin. Lee AY, Fredenburgh JC, Stewart RJ, Rischke JA, Weitz JI. Thromb Haemost; 2001 Mar 21; 85(3):502-8. PubMed ID: 11307822 [Abstract] [Full Text] [Related]
15. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade. Kumada M, Niwa M, Hara A, Matsuno H, Mori H, Ueshima S, Matsuo O, Yamamoto T, Kozawa O. Invest Ophthalmol Vis Sci; 2005 Apr 21; 46(4):1504-7. PubMed ID: 15790922 [Abstract] [Full Text] [Related]
16. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K. J Cell Physiol; 2005 May 21; 203(2):447-56. PubMed ID: 15605379 [Abstract] [Full Text] [Related]
17. Tenascin-C triggers fibrin accumulation by downregulation of tissue plasminogen activator. Brellier F, Hostettler K, Hotz HR, Ozcakir C, Çöloğlu SA, Togbe D, Ryffel B, Roth M, Chiquet-Ehrismann R. FEBS Lett; 2011 Mar 23; 585(6):913-20. PubMed ID: 21354146 [Abstract] [Full Text] [Related]
18. Endogenous urokinase lacks antifibrotic activity during progressive renal injury. Yamaguchi I, Lopez-Guisa JM, Cai X, Collins SJ, Okamura DM, Eddy AA. Am J Physiol Renal Physiol; 2007 Jul 23; 293(1):F12-9. PubMed ID: 17356128 [Abstract] [Full Text] [Related]
19. Extrinsic plasminogen activator: a new principle in fibrinolysis. Lijnen HR. Behring Inst Mitt; 1983 Aug 23; (73):43-55. PubMed ID: 6236789 [Abstract] [Full Text] [Related]
20. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis. Bai X, Weitz JI, Gross PL. Thromb Haemost; 2009 Dec 23; 102(6):1212-8. PubMed ID: 19967153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]